Ask what Korea is talking about.

Starting Dec 12, people who have legally purchased weight-loss drugs overseas can bring up to a three-month supply into Korea, Yonhap reports. The Ministry of Food and Drug Safety also issued a safety alert Wednesday to medical professionals and patients over a potential risk of a rare eye condition linked to GLP-1 obesity drugs, including popular obesity treatments, according to the Korea Times. Korean media coverage focuses on the regulatory change and the safety warning, with the Korea Economic Daily noting that drugs such as Mounjaro and Wegovy purchased abroad can be brought into the country from Dec 12.